PMID- 31137122 OWN - NLM STAT- MEDLINE DCOM- 20190604 LR - 20190604 IS - 0376-2491 (Print) IS - 0376-2491 (Linking) VI - 99 IP - 18 DP - 2019 May 14 TI - [Clinical characteristics and classification diagnosis of newly diagnosed diabetes onset with ketosis or ketoacidosis in adult patients]. PG - 1369-1374 LID - 10.3760/cma.j.issn.0376-2491.2019.18.003 [doi] AB - Objective: To describe the clinical characteristics and classification diagnosis of newly diagnosed diabetes onset with ketosis or ketoacidosis in adult patients. Methods: Medical records of newly diagnosed diabetes onset with ketosis or ketoacidosis in the Third Affiliated Hospital of Sun Yat-sen University between January 2011 and August 2016 were reviewed. Patients aged 18 years or older were included, while other diseases that may cause urinary ketoacidosis and special types of diabetes were excluded. Patients were classified as type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) or diabetes mellitus untyped based on discharged diagnosis, and groups were compared for differences in clinical profiles. Then the patient's medication, final diagnosis and outcome within 2 years of discharge were tracked through the inpatient and the outpatient medical record systems. Receiver operating characteristics (ROC) curves were analyzed to check the ability of clinical indicators such as onset age, body mass index (BMI) and C-peptide to discriminate T1DM from T2DM, and to find the best diagnostic cut-off points. Results: A total of 123 patients (88 males) were enrolled [with a mean age of (41.1+/-13.6) years old], with 37 patients (30.1%) diagnosed as T1DM, 60 patients (48.8%) diagnosed as T2DM and 26 patients (21.1%) diagnosed as Untyped. There was a statistically significant difference in onset age, BMI, blood pressure, blood gas pH and bicarbonate, blood lipids, fasting, 0.5 h and 2 h C-peptide level, any diabetic antibody and anti-glutamic acid decarboxylase antibody (GADA) positive rate, combined fatty liver ratio and family history among the three groups (all P<0.05). ROC curve analysis was performed on patients diagnosed with T1DM (n=36) and T2DM (n=87) after 2 years follow-up, and the area under the curve (AUC) of onset age, BMI, fasting C-peptide, 0.5 h and 2 h C-peptide was 0.735, 0.813, 0.855, 0.898, and 0.882, respectively. Conclusion: The ROC curve analysis indicates that C-peptide, onset age and BMI can provide effective diagnostic value, and the diagnostic value of C peptide is better than BMI and onset age. FAU - Liu, H X AU - Liu HX AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Li, G M AU - Li GM AD - Department of Endocrinology, Qujing First People's Hospital, Qujing 655000, Yunnan, China. FAU - Zhou, Y W AU - Zhou YW AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Luo, S H AU - Luo SH AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Zheng, X Y AU - Zheng XY AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Yang, D Z AU - Yang DZ AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Liang, H AU - Liang H AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Yan, J H AU - Yan JH AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Yao, B AU - Yao B AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. FAU - Weng, J P AU - Weng JP AD - Department of Endocrinology and Metabolic Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China. LA - chi GR - 2017YFC1309603/National Key Research and Development Program of China/ GR - 2017A070713011/Guangdong Science and Technology Plan/ GR - 201508020027/Guangzhou Science and Technology Plan/ PT - Journal Article PL - China TA - Zhonghua Yi Xue Za Zhi JT - Zhonghua yi xue za zhi JID - 7511141 RN - 0 (C-Peptide) RN - EC 4.1.1.15 (Glutamate Decarboxylase) SB - IM MH - Adult MH - C-Peptide MH - *Diabetes Mellitus, Type 1 MH - *Diabetes Mellitus, Type 2 MH - Female MH - Glutamate Decarboxylase MH - Humans MH - *Ketosis MH - Male MH - Middle Aged OTO - NOTNLM OT - Diabetes mellitus, type 1 OT - Diabetes mellitus, type 2 OT - Diabetic ketoacidosis EDAT- 2019/05/30 06:00 MHDA- 2019/06/05 06:00 CRDT- 2019/05/29 06:00 PHST- 2019/05/29 06:00 [entrez] PHST- 2019/05/30 06:00 [pubmed] PHST- 2019/06/05 06:00 [medline] AID - 10.3760/cma.j.issn.0376-2491.2019.18.003 [doi] PST - ppublish SO - Zhonghua Yi Xue Za Zhi. 2019 May 14;99(18):1369-1374. doi: 10.3760/cma.j.issn.0376-2491.2019.18.003.